Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Cheaper, better disease treatments expected from faster approach to developing antibodies
May 2nd, 2007
A method of mass-producing disease-fighting antibodies entirely within bacteria has been developed by a research group at The University of Texas at Austin. The group led by Dr. George Georgiou developed the new antibody-production approach to improve upon processes used previously to identify new drugs. Drug companies have used those more time- and labor-intensive processes to develop antibodies for treating rheumatoid arthritis, cancer and other diseases. The new approach developed in collaboration with Dr. Brent Iverson overcomes those obstacles, and has other advantages. "Our approach can provide a significant time savings,"...
Source: Biotech Week (2007-05-02)
|
